Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.500
-0.010 (-0.66%)
Sep 23, 2026, 9:54 AM EDT - Market open
Imunon Employees
Imunon had 20 employees as of December 31, 2025. The number of employees decreased by 5 or -20.00% compared to the previous year.
Employees
20
Change (1Y)
-5
Growth (1Y)
-20.00%
Revenue / Employee
n/a
Profits / Employee
-$736,658
Market Cap
8.42M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 20 | -5 | -20.00% |
| Dec 31, 2024 | 25 | -8 | -24.24% |
| Dec 31, 2023 | 33 | 2 | 6.45% |
| Dec 31, 2022 | 31 | 2 | 6.90% |
| Dec 31, 2021 | 29 | 2 | 7.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Longeveron | 38 |
| Evogene | 38 |
| Soligenix | 14 |
| CNS Pharmaceuticals | 8 |
| Traws Pharma | 7 |
| Enveric Biosciences | 6 |
| XTL Biopharmaceuticals | 5 |
IMNN News
- 1 day ago - Imunon announces IDMC recommends continued Phase 2 development of IMNN-001 - TheFly
- 1 day ago - IMUNON Reports Independent Data Monitoring Committee Recommends Continued Phase 2 Development of IMNN-001 Following Favorable Safety Review - GlobeNewsWire
- 13 days ago - Imunon enters CRADA with National Cancer Institute for IMNN-001 development - TheFly
- 13 days ago - IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001 - GlobeNewsWire
- 14 days ago - IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress - GlobeNewsWire
- 4 weeks ago - IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001 - GlobeNewsWire
- 6 weeks ago - Imunon Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Imunon Earnings release: Q2 2026 - Filings